Format

Send to

Choose Destination
Br J Clin Pharmacol. 2019 Aug;85(8):1855-1858. doi: 10.1111/bcp.13967. Epub 2019 Jun 17.

Ticagrelor and central sleep apnoea: Impact of withdrawal and reintroduction.

Author information

1
PEAS, Nouvelle Clinique Bel-Air, Bordeaux, France.
2
Département de Pharmacologie Médicale, Centre Régional de Pharmacovigilance, CHU Bordeaux, Bordeaux, France.
3
INSERM, Bordeaux Population Health Research Center, team Pharmacoepidemiology, UMR 1219, Université de Bordeaux, Bordeaux, France.
4
Cardiology/Hypertension Department, University Hospital of Bordeaux, Bordeaux, France.
5
Institut National de la Santé et de la Recherche Médicale (INSERM), U 1042, HP2 Laboratory (Hypoxia: Pathophysiology), University Grenoble Alpes, Grenoble, France.
PMID:
31206207
PMCID:
PMC6624382
[Available on 2020-08-01]
DOI:
10.1111/bcp.13967

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center